Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma

Journal of Biological Chemistry

Volumn 289, Issue 20, 2014, Pages 13974-13985

  Qin, Yu ^a   Fu, Maoyong ^a   Takahashi, Masamichi ^a   Iwanami, Akio ^a   Kuga, Daisuke ^a   Rao, Rajiv G ^a   Sudhakar, Deepthi ^a   Huang, Tiffany ^a   Kiyohara, Meagan ^a   Torres, Kathleen ^a   Dillard, Christen ^a   Inagaki, Akihito ^a   Kasahara, Noriyuki ^a   Goodglick, Lee ^a   Braun, Jonathan ^a   Mischel, Paul S ^b,c   Gordon, Lynn K ^a   Wadehra, Madhuri ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; ENZYMES; MAMMALS; TUMORS;

EPITHELIAL MEMBRANES; FOCAL ADHESION KINASE; MOLECULAR CLASSIFICATION; PROOF OF PRINCIPLES; SURFACE EXPRESSION; THERAPEUTIC TARGETS; THERAPEUTIC TREATMENTS; TUMOR CELL INVASION;

PROTEINS;

EPITHELIAL MEMBRANE PROTEIN 2; FOCAL ADHESION KINASE; PROTEIN TYROSINE KINASE; TETRASPANIN; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; EMP2 PROTEIN, HUMAN; FOCAL ADHESION KINASE 1; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR CELL; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; ANIMAL; CELL PROLIFERATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHENOTYPE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR TARGETED THERAPY; PHENOTYPE; SRC-FAMILY KINASES;

EID: 84901020087     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.543728     Document Type: Article

References (51)

1. Rolle, C. E., Sengupta, S., and Lesniak, M. S. (2010) Challenges in clinical design of immunotherapy trials for malignant glioma. Neurosurg. Clin. N. Am. 21, 201-214
2. Teodorczyk, M., and Martin-Villalba, A. (2010) Sensing invasion: cell surface receptors driving spreading of glioblastoma. J. Cell. Physiol. 222, 1-10
3. Wang, S. D., Rath, P., Lal, B., Richard, J. P., Li, Y., Goodwin, C. R., Laterra, J., and Xia, S. (2012) EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase. Oncogene 31, 5132-5143
4. Giese, A., Loo, M. A., Tran, N., Haskett, D., Coons, S. W., and Berens, M. E. (1996) Dichotomy of astrocytoma migration and proliferation. Int. J. Cancer 67, 275-282
5. Zagzag, D., Lukyanov, Y., Lan, L., Ali, M. A., Esencay, M., Mendez, O., Yee, H., Voura, E. B., and Newcomb, E. W. (2006) Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab. Invest. 86, 1221-1232
6. de Groot, J., and Milano, V. (2009) Improving the prognosis for patients with glioblastoma: the rationale for targeting Src. J. Neurooncol. 95, 151-163
7. Wick, W., Weller, M., Weiler, M., Batchelor, T., Yung, A. W., and Platten, M. (2011) Pathway inhibition: emerging molecular targets for treating glioblastoma. Neuro-Oncology 13, 566-579
8. Fu, M., Rao, R., Sudhakar, D., Hogue, C. P., Rutta, Z., Morales, S., Gordon, L. K., Braun, J., Goodglick, L., and Wadehra, M. (2011) Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src. PLoS One 6, e19945
9. Morales, S. A., Mareninov, S., Wadehra, M., Zhang, L., Goodglick, L., Braun, J., and Gordon, L. K. (2009) FAK activation and the role of epithelial membrane protein 2 (EMP2) in collagen gel contraction. Invest. Ophthalmol. Vis. Sci. 50, 462-469
10. Habeeb, O., Goodglick, L., Soslow, R. A., Rao, R. G., Gordon, L. K., Schirripa, O., Horvath, S., Braun, J., Seligson, D. B., and Wadehra, M. (2010) Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development. Cancer 116, 4718-4726
11. Fu, M., Maresh, E. L., Soslow, R. A., Alavi, M., Mah, V., Zhou, Q., Iasonos, A., Goodglick, L., Gordon, L. K., Braun, J., and Wadehra, M. (2010) Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer. Clin. Cancer Res. 16, 3954-3963
12. Fu, M., Maresh, E. L., Helguera, G., Kiyohara, M., Qin, Y., Ashki, N., Daniels- Wells, T.R., Aziz, N., Gordon, L.K., Braun, J., Elshimali, Y., Soslow, R.A., Penichet, M.L., Goodglick, L., and Wadehra, M.(2014) Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer. Mol. Cancer Ther., in press 10.1158/1535-7163.MCT-13-0199
13. Wadehra, M., Natarajan, S., Seligson, D. B., Williams, C. J., Hummer, A. J., Hedvat, C., Braun, J., and Soslow, R. A. (2006) Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome. Cancer 107, 90-98
14. Freije, W. A., Castro-Vargas, F. E., Fang, Z., Horvath, S., Cloughesy, T., Liau, L. M., Mischel, P. S., and Nelson, S. F. (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 64, 6503-6510
15. Wang, Y., Zhu, S., Cloughesy, T. F., Liau, L. M., and Mischel, P. S. (2004) p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition. Oncogene 23, 1283-1290
16. Wang, M. Y., Lu, K. V., Zhu, S., Dia, E. Q., Vivanco, I., Shackleford, G. M., Cavenee, W. K., Mellinghoff, I. K., Cloughesy, T. F., Sawyers, C. L., and Mischel, P. S. (2006) Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. Cancer Res. 66, 7864-7869
17. Kim, K., Brush, J. M., Watson, P. A., Cacalano, N. A., Iwamoto, K. S., and McBride, W. H. (2008) Epidermal growth factor receptor vIII expression in U87 glioblastoma cells alters their proteasome composition, function, and response to irradiation. Mol. Cancer Res. 6, 426-434
18. Gordon, L. K., Kiyohara, M., Fu, M., Braun, J., Dhawan, P., Chan, A., Goodglick, L., and Wadehra, M. (2013) EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF. Oncogene 32, 5369-5376
19. Wadehra, M., Forbes, A., Pushkarna, N., Goodglick, L., Gordon, L. K., Williams, C. J., and Braun, J. (2005) Epithelial membrane protein-2 regulates surface expression ofαvβ3 integrin in the endometrium. Dev. Biol. 287, 336-345
20. Wadehra, M., Dayal, M., Mainigi, M., Ord, T., Iyer, R., Braun, J., and Williams, C. J. (2006) Knockdown of the tetraspan protein epithelial membrane protein-2 inhibits implantation in the mouse. Dev. Biol. 292, 430-441
21. Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H., Chute, D. J., Riggs, B. L., Horvath, S., Liau, L. M., Cavenee, W. K., Rao, P. N., Beroukhim, R., Peck, T. C., Lee, J. C., Sellers, W. R., Stokoe, D., Prados, M., Cloughesy, T. F., Sawyers, C. L., and Mischel, P. S. (2005) Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N. Engl. J. Med. 353, 2012-2024
22. Cronin, M., Akin, A. R., Collins, S. A., Meganck, J., Kim, J.-B., Baban, C. K., Joyce, S. A., van Dam, G. M., Zhang, N., van Sinderen, D., O'Sullivan, G. C., Kasahara, N., Gahan, C. G., Francis, K. P., and Tangney, M. (2012) High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting. PLoS One 7, e30940
23. Agus, D. B., Scher, H. I., Higgins, B., Fox, W. D., Heller, G., Fazzari, M., Cordon-Cardo, C., and Golde, D. W. (1999) Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models. Cancer Res. 59, 4761-4764
24. Wang, W., Zhu, N. L., Chua, J., Swenson, S., Costa, F. K., Schmitmeier, S., Sosnowski, B. A., Shichinohe, T., Kasahara, N., and Chen, T. C. (2005) Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy. J. Neurosurg. 103, 1058-1066
25. Huang, T. T., Hlavaty, J., Ostertag, D., Espinoza, F. L., Martin, B., Petznek, H., Rodriguez-Aguirre, M., Ibañez, C. E., Kasahara, N., Gunzburg, W., Gruber, H. E., Pertschuk, D., Jolly, D. J., and Robbins, J. M. (2013) Toca 511gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model. Cancer Gene Ther. 20, 544-551
26. Shimazaki, K., Lepin, E. J., Wei, B., Nagy, A. K., Coulam, C. P., Mareninov, S., Fu, M., Wu, A. M., Marks, J. D., Braun, J., Gordon, L. K., and Wadehra, M. (2008) Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines. Clin. Cancer Res. 14, 7367-7377
27. Acconcia, F., Barnes, C. J., and Kumar, R. (2006) Estrogen and tamoxifen induce cytoskeletal remodeling and migration in endometrial cancer cells. Endocrinology 147, 1203-1212
28. Wadehra, M., Sulur, G. G., Braun, J., Gordon, L. K., and Goodglick, L. (2003) Epithelial membrane protein-2 is expressed in discrete anatomical regions of the eye. Exp. Mol. Pathol. 74, 106-112
29. Abramoff, M. D., Magelhaes, P. J., and Ram, S. J. (2004) Image processing with ImageJ. Biophotonics Int. 11, 36-42
30. Fan, Q.-W., Cheng, C. K., Gustafson, W. C., Charron, E., Zipper, P., Wong, R. A., Chen, J., Lau, J., Knobbe-Thomsen, C., Weller, M., Jura, N., Reifenberger, G., Shokat, K. M., and Weiss, W. A. (2013) EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer Cell 24, 438-449
31. Hood, J. D., and Cheresh, D. A. (2002) Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2, 91-100
32. Charo, I. F., Nannizzi, L., Smith, J. W., and Cheresh, D. A. (1990) The vitronectin receptorαvβ3 binds fibronectin and acts in concert withα5β1 in promoting cellular attachment and spreading on fibronectin. J. Cell Biol. 111, 2795-2800
33. Jiao, Y., Feng, X., Zhan, Y., Wang, R., Zheng, S., Liu, W., and Zeng, X. (2012) Matrix metalloproteinase-2 promotes αvβ3 integrin-mediated adhesion and migration of human melanoma cells by cleaving fibronectin. PLoS One 7, e41591
34. Kerr, J. S., Slee, A. M., and Mousa, S. A. (2000) Small molecule αv integrin antagonists: novel anticancer agents. Expert Opin. Investig. Drugs 9, 1271-1279
35. Rooprai, H. K., Vanmeter, T., Panou, C., Schnüll, S., Trillo-Pazos, G., Davies, D., and Pilkington, G. J. (1999) The role of integrin receptors in aspects of glioma invasion in vitro. Int. J. Dev. Neurosci. 17, 613-623
36. Mitra, S. K., and Schlaepfer, D. D. (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 18, 516-523
37. Hehlgans, S., Haase, M., and Cordes, N. (2007) Signalling via integrins: implications for cell survival and anticancer strategies. Biochim. Biophys. Acta 1775, 163-180
38. Beckman, R. A., Weiner, L. M., and Davis, H. M. (2007) Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors. Cancer 109, 170-179
39. Buonerba, C., Di Lorenzo, G., Marinelli, A., Federico, P., Palmieri, G., Imbimbo, M., Conti, P., Peluso, G., De Placido, S., and Sampson, J. H. (2011) A comprehensive outlook on intracerebral therapy of malignant gliomas. Crit. Rev. Oncol. Hematol. 80, 54-68
40. Petrás, M., Hutóczki, G., Varga, I., Vereb, G., Szöllosi, J., Bognár, L., Ruszthi, P., Kenyeres, A., Tóth, J., Hanzély, Z., Scholtz, B., and Klekner, A. (2009) Expression pattern of invasion-related molecules in brain tumors of different origin. Magy. Onkol. 53, 253-258
41. Kanamori, M., Kawaguchi, T., Berger, M. S., and Pieper, R. O. (2006) Intracranial microenvironment reveals independent opposing functions of host αVβ3 expression on glioma growth and angiogenesis. J. Biol. Chem. 281, 37256-37264
42. D'Abaco, G. M., and Kaye, A. H. (2007) Integrins: molecular determinants of glioma invasion. J. Clin. Neurosci. 14, 1041-1048
43. Gladson, C. L., and Cheresh, D. A. (1991) Glioblastoma expression of vitronectin and the αvβ3 integrin. Adhesion mechanism for transformed glial cells. J. Clin. Invest. 88, 1924-1932
44. Wadehra, M., Iyer, R., Goodglick, L., and Braun, J. (2002) The tetraspan protein epithelial membrane protein-2 interacts with β1 integrins and regulates adhesion. J. Biol. Chem. 277, 41094-41100
45. Lorger, M., and Felding-Habermann, B. (2012) in Integrin Signaling in Angiogenesis and Metastatic Cancer Progression in the Brain Signaling Pathways and Molecular Mediators in Metastasis (Fatatis, A., ed) pp. 311-329, Springer, Netherlands
46. Kawaguchi, T., Yamashita, Y., Kanamori, M., Endersby, R., Bankiewicz, K. S., Baker, S. J., Bergers, G., and Pieper, R. O. (2006) The PTEN/Akt pathway dictates the direct αVβ3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo. Cancer Res. 66, 11331-11340
47. Chang, M.-W., Lo, J.-M., Juan, H.-F., Chang, H.-Y., and Chuang, C.-Y. (2012) Combination of RGD compound and low-dose paclitaxel induces apoptosis in human glioblastoma cells. PLoS One 7, e37935
48. Kerbel, R. S. (2008) Tumor angiogenesis. N. Engl. J. Med. 358, 2039-2049
49. Frank, R. T., Aboody, K. S., and Najbauer, J. (2011) Strategies for enhancing antibody delivery to the brain. Biochim. Biophys. Acta 1816, 191-198
50. McEarchern, J. A., Oflazoglu, E., Francisco, L., McDonagh, C. F., Gordon, K. A., Stone, I., Klussman, K., Turcott, E., van Rooijen, N., Carter, P., Grewal, I. S., Wahl, A. F., and Law, C.-L. (2007) Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities. Blood 109, 1185-1192
51. Fukai, J., Nishio, K., Itakura, T., and Koizumi, F. (2008) Antitumor activity of cetuximab against malignant glioma cells over expressing EGFR deletion mutant variant III. Cancer Sci. 99, 2062-2069